Data as at IST. Index data may be delayed by up to 20 minutes. For real-time updates, kindly refer to the BSE and NSE websites.
J K Pharmachem Share Price
Know MoreBSE : 500218
NSE : JKPHARMA
Sector : Health care
ISIN Code : INE335C01018
| Market Cap (₹ Cr) | - |
Traded Value (₹ Cr) | 0.00 |
Volume (Shares) | - |
52-Week High (₹) | 0.00 |
52-Week High Date | - |
52-Week Low (₹) | 0.00 |
52-Week Low Date | - |
All Time High (₹) | 32.50 |
All Time High Date | 06-Mar-1995 |
All Time Low (₹) | - |
All Time Low Date | - |
J K Pharmachem Ltd
Market News
J K Pharmachem Announcement
J K Pharmachem Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| UTI-Conservative Hybrid Fund - (G) | 0.00 | 13,82,619 | 0.00 |
| UTI-Conservative Hybrid Fund - (IDCW-M) | 0.00 | 13,82,619 | 0.00 |
| UTI-Conservative Hybrid Fund - Monthly Payment | 0.00 | 13,82,619 | 0.00 |
| UTI-Conservative Hybrid Fund - Flexi (IDCW) | 0.00 | 13,82,619 | 0.00 |
| UTI-Conservative Hybrid Fund - Direct (G) | 0.00 | 13,82,619 | 0.00 |
| UTI-Conservative Hybrid Fund - Direct (IDCW-M) | 0.00 | 13,82,619 | 0.00 |
| UTI-Conservative Hybrid Fund - Direct (IDCW-Flexi) | 0.00 | 13,82,619 | 0.00 |
| UTI-Conservative Hybrid Fund - Direct (Monthly-Paymen) | 0.00 | 13,82,619 | 0.00 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Year Low/High (₹) | 0.00 0.00 |
| All time Low/High (₹) | 1.10 37.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | - | - | 22.97% | 27.64% |
| 1 Month | - | - | 19.03% | 23.24% |
| 3 Month | - | - | 19.93% | 24.47% |
| 6 Month | - | - | 25.04% | 29.23% |
| 1 Year | - | - | 24.11% | 27.96% |
| 3 Year | - | - | 82.98% | 91.93% |
Company Info
Company Information
Director : Deep Chandra Jain
Nominee (UTI) : Kailash Bhansali
Director : Prakash Chandra Jain
Director : Pramod Kapoor
Director : Sudhir A Bidkar
Director : S K Sagar
Nominee (TIDCO) : T S Surendranath
Director : V P Vig
Deputy Company Secretary : Shweta Girotra
FAQs about J K Pharmachem Ltd
6. Which are J K Pharmachem Ltd’s peers in the Health care sector?
J K Pharmachem Ltd’s top 5 peers in the Health care sector are Fabino Enter, Brawn Biotech, Raymed Labs.
7. Who owns how much in J K Pharmachem Ltd?
Key changes to the J K Pharmachem Ltd shareholding are as follows:
- Promoter holding in J K Pharmachem Ltd has gone down to 36.45 per cent as of Jun 2005 from 36.61 per cent as of Sep 2004.
